{
  "url": "https://voxday.net/2019/01/31/help-end-crohns-disease/",
  "scraped_at": "2025-12-20T05:27:59.014608",
  "title": "Help end Crohn’s disease",
  "date_display": "January 31, 2019",
  "date_iso": "2019-01-31T01:37:04+00:00",
  "date_from_url": "2019-01-31",
  "author": "VD",
  "content_html": "<div class=\"entry-content\"><p>The development of the vaccine that many members of this blog have helped fund is at last entering human trials. If you’re in the UK, you’re healthy, and you’re willing to put your body on the line to help cure Crohn’s disease, please consider <a href=\"https://www.jenner.ac.uk/_asset/file/hav001-vis-3-0.pdf\">volunteering for the trial</a>.</p><blockquote><p>HAV001 Vaccine Trial<br>What is the purpose of this trial?</br></p><p>The purpose of this study is to assess the new MAP vaccines, ChAdOx2 HAV and MVA HAV, at different doses. The study will enable us to assess the safety of the vaccines and the extent of the immune response in healthy volunteers. We will do this by giving participants one or two vaccines in addition to doing blood tests and collecting information about any symptoms that occur after vaccination. This is the first trial to use these vaccines in humans and we plan to recruit a maximum of 18 participants to be vaccinated.</p><p>What’s involved?</p><p>Number of visits: 7-12</p><p>Trial length: 3-5 months</p><p>Location: OX3 7LE</p><p>Am I eligible to participate?<br>You must:</br></p><p>Be aged 18-50 years old<br>Be in good health<br>Refrain from blood donation for the duration of the study</br></br></p></blockquote><p>One Darkstream listener has already volunteered. This is a big step, as once the vaccine is proven to be harmless to healthy adults, they’ll be able to test its ability to eradicate the disease from those suffering from it.</p></div>",
  "content_text": "The development of the vaccine that many members of this blog have helped fund is at last entering human trials. If you’re in the UK, you’re healthy, and you’re willing to put your body on the line to help cure Crohn’s disease, please consider\nvolunteering for the trial\n.\nHAV001 Vaccine Trial\nWhat is the purpose of this trial?\nThe purpose of this study is to assess the new MAP vaccines, ChAdOx2 HAV and MVA HAV, at different doses. The study will enable us to assess the safety of the vaccines and the extent of the immune response in healthy volunteers. We will do this by giving participants one or two vaccines in addition to doing blood tests and collecting information about any symptoms that occur after vaccination. This is the first trial to use these vaccines in humans and we plan to recruit a maximum of 18 participants to be vaccinated.\nWhat’s involved?\nNumber of visits: 7-12\nTrial length: 3-5 months\nLocation: OX3 7LE\nAm I eligible to participate?\nYou must:\nBe aged 18-50 years old\nBe in good health\nRefrain from blood donation for the duration of the study\nOne Darkstream listener has already volunteered. This is a big step, as once the vaccine is proven to be harmless to healthy adults, they’ll be able to test its ability to eradicate the disease from those suffering from it.",
  "tags": [
    "science"
  ],
  "categories": [],
  "sitemap_lastmod": "2019-01-31T01:37:04+00:00"
}